Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C VanCott

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virology|November 13, 1998
Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140N M Stamatos, J R Mascola, V S Kalyanaraman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1T C VanCott, F R Bethke, V R Polonis, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
The Journal of Biological Chemistry|June 16, 2005
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigensAnastas Pashov, Gabriela Canziani, Behjatolah Monzavi-Karbassi, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Detection of mucosal antibodies in HIV type 1-infected individualsPeter F Wright, Pamela A Kozlowski, G Kyle Rybczyk, et al.
Military Medicine|October 24, 2019
Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. ConflictsHari Krishna Raju Sagiraju, Sasa Živković, Anne C VanCott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccinesS H Pincus, K G Messer, R Cole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1Selvi B Williams, Timothy P Flanigan, Susan Cu-Uvin, et al.
The Journal of Infectious Diseases|October 2, 2002
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milkCarey Farquhar, Thomas C VanCott, Dorothy A Mbori-Ngacha, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|November 13, 1998
Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140N M Stamatos, J R Mascola, V S Kalyanaraman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1T C VanCott, F R Bethke, V R Polonis, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
The Journal of Biological Chemistry|June 16, 2005
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigensAnastas Pashov, Gabriela Canziani, Behjatolah Monzavi-Karbassi, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Detection of mucosal antibodies in HIV type 1-infected individualsPeter F Wright, Pamela A Kozlowski, G Kyle Rybczyk, et al.
Military Medicine|October 24, 2019
Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. ConflictsHari Krishna Raju Sagiraju, Sasa Živković, Anne C VanCott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccinesS H Pincus, K G Messer, R Cole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1Selvi B Williams, Timothy P Flanigan, Susan Cu-Uvin, et al.
The Journal of Infectious Diseases|October 2, 2002
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milkCarey Farquhar, Thomas C VanCott, Dorothy A Mbori-Ngacha, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
Pageof 8